Jae Ho Jeong
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 28
- Cancer Treatment and Pharmacology 15
- HER2/EGFR in Cancer Research 13
- Cancer Immunotherapy and Biomarkers 11
- Cancer Research top 10%
- Breast Cancer Treatment Studies 22
- Cancer Genomics and Diagnostics 18
- Surgery top 5%
- Cholangiocarcinoma and Gallbladder Cancer Studies 21
-
- Advanced Breast Cancer Therapies 12
- Internal Medicine top 10%
- Co-authors
- Baek‐Yeol RyooChanghoon YooKyu‐pyo KimJaekyung CheonDae Wook HwangHeung-Moon ChangByung Chae ChoHyewon Ryu
- Cited by
- OncologyCancer ResearchSurgery
- Journals
- Journal of Clinical Oncology (12 papers)Cancer Research and Treatment (10 papers)Cancers (6 papers)
- Partner nations
- South KoreaUnited StatesChina
In The Last Decade
Jae Ho Jeong
111 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 103
- Oncology 832
- Cancer Research 277
- Surgery 701
- Pulmonary and Respiratory Medicine 429
- Internal Medicine 31
Countries citing papers authored by Jae Ho Jeong
This map shows the geographic impact of Jae Ho Jeong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jae Ho Jeong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jae Ho Jeong more than expected).
Fields of papers citing papers by Jae Ho Jeong
This network shows the impact of papers produced by Jae Ho Jeong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jae Ho Jeong. The network helps show where Jae Ho Jeong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jae Ho Jeong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 17 | |
| 11 | 2022 | 2 | |
| 12 | 2021 | 3 | |
| 13 | 2021 | 12 | |
| 14 | 2019 | 34 | |
| 15 | 2019 | 59 | |
| 16 | 2017 | 33 | |
| 17 | Proteasome-Inhibitor-Based Primary Therapy for Antibody-Mediated Rejection in a Renal Transplant Recipient | 2011 | 0 |
| 18 | A Case of MELAS Syndrome Diagnosed in a Woman in Her 50s | 2011 | 0 |
| 19 | Subcutaneous Mastectomy with Immediate Reconstruction as Treatment for Early Breast Carcinomas | 1999 | 1 |
| 20 | SURVIVAL PATTERN OF PREVIOUSLY EXPANDED ARTERIALIZED VENOUS FLAPS | 1997 | 5 |
About Jae Ho Jeong
Jae Ho Jeong is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 129 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (28 papers), Breast Cancer Treatment Studies (22 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (21 papers), Cancer Genomics and Diagnostics (18 papers), Cancer Treatment and Pharmacology (15 papers), HER2/EGFR in Cancer Research (13 papers), Advanced Breast Cancer Therapies (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). The work is most often cited by research in Oncology (832 citations), Cancer Research (277 citations) and Surgery (701 citations). Jae Ho Jeong has collaborated with scholars based in South Korea, United States and China. Frequent co-authors include Baek‐Yeol Ryoo, Changhoon Yoo, Kyu‐pyo Kim, Jaekyung Cheon, Dae Wook Hwang, Heung-Moon Chang, Byung Chae Cho, Hyewon Ryu, Il Hwan Kim and Tae Jun Song. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Treatment, Cancers, European Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.